Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat
Takeda’s Skyline study in Dravet syndrome narrowly missed its primary endpoint of reduction in convulsive seizure frequency and showed clinically […]
AMC Networks Inc. Announces Private Offering of $125 Million of Convertible Senior Notes
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — AMC Networks Inc. (Nasdaq: AMCX) (the “Company” or “AMC Networks”) today announced […]
Gilat to Acquire Stellar Blu, an IFC Market Leader with a First-to-Market ESA-Based Solution for Commercial Aviation
Highlights The acquisition positions Gilat as a market leader in In-Flight Connectivity (IFC) technologies and solutions for Commercial and Business […]
Shoals Technologies Group to Launch Global Suite of Solutions at Intersolar Europe
PORTLAND, Tenn., June 17, 2024 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance […]
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous immunoglobulins to meet strong demand Yimmugo, already […]
Red Cat Introduces New Family of Low-Cost, Portable Unmanned Reconnaissance and Precision Lethal Strike Systems
SAN JUAN, Puerto Rico, June 17, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat”), a drone technology […]
United Selects Magnite’s SpringServe to Power Advertising Solution for Inflight Personal Device Entertainment
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced it […]
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 17, 2024 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage […]
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market Infrastructure
Technology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products […]
argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024
R&D Day presentations to include recent Phase 2 datasets in Sjogren’s disease (efgartigimod) and multifocal motor neuropathy (empasiprubart) that support […]
